Molecular Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarz, J. K.
Right arrow Articles by Piwnica-Worms, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarz, J. K.
Right arrow Articles by Piwnica-Worms, H.
Molecular Cancer Research 1:598-609 (2003)
© 2003 American Association for Cancer Research


DNA Damage and Cellular Stress Responses

Regulation of the Chk2 Protein Kinase by Oligomerization-Mediated cis- and trans-Phosphorylation1

Julie K. Schwarz1, Christine M. Lovly1 and Helen Piwnica-Worms1,2,3

Departments of 1 Cell Biology and Physiology and 2 Internal Medicine, Washington University School of Medicine, St. Louis, MO; and 3 Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO

Requests for reprints: Christine M. Lovly, Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8228, St. Louis, MO 63110. Phone: (314) 362-6834; Fax: (314) 362-3709. E-mail: lovlyc{at}msnotes.wustl.edu

Chk2 is a serine/threonine protein kinase found mutated in certain hereditary and sporadic cancers. Ionizing radiation (IR) activates the kinase activity of Chk2 in a phosphorylation-dependent manner. ATM phosphorylates Chk2 on threonine 68, which promotes oligomerization and phosphorylation on threonines 383 and 387 within the activation loop of the catalytic domain. In this study, threonines 68, 383, and 387 were confirmed as sites of Chk2 phosphorylation both in vitro and in vivo. In addition, serine 516 was identified as a novel IR-inducible phosphorylation site in vivo and as a site of autophosphorylation in vitro. Interestingly, Chk2 was capable of autoactivation in the absence of IR when overproduced in bacteria, in 293 cells, and in murine embryonic fibroblasts lacking Chk2. A kinase-inactive mutant of Chk2 was phosphorylated on T68 and T383/T387 but not on S516 in cells containing Chk2 and on T68 but not T383/T387 or S516 in cells lacking Chk2. This establishes a dependency on Chk2 kinase activity for phosphorylation of T383/T387 and S516 but not for T68 in vivo. We demonstrate that T68 phosphorylation is regulated by kinases in addition to ATM and Chk2. Taken together, our data indicate that autophosphorylation of Chk2 can occur both in cis and in trans and suggest that oligomerization may regulate Chk2 activation by promoting these cis- and trans-phosphorylation events. The importance of oligomerization is underscored by the observation that substitution of isoleucine for threonine at position 157, a mutation found in a subset of patients with Li-Fraumeni syndrome, impairs both Chk2 oligomerization and autophosphorylation.

Key Words: Chk2 • Checkpoints • DNA damage • Li-Fraumeni syndrome • p53




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. M. Kass, J. Ahn, T. Tanaka, W. A. Freed-Pastor, S. Keezer, and C. Prives
Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456
J. Biol. Chem., October 12, 2007; 282(41): 30311 - 30321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Gupta, X. Guo, S. S. Durkin, K. F. Fryrear, M. D. Ward, and O. J. Semmes
Human T-cell Leukemia Virus Type 1 Tax Oncoprotein Prevents DNA Damage-induced Chromatin Egress of Hyperphosphorylated Chk2
J. Biol. Chem., October 5, 2007; 282(40): 29431 - 29440.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
V. A. Rao, C. Conti, J. Guirouilh-Barbat, A. Nakamura, Z.-H. Miao, S. L. Davies, B. Sacca, I. D. Hickson, A. Bensimon, and Y. Pommier
Endogenous {gamma}-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase Deficient Cells Is Related to DNA Replication Arrested Forks
Mol. Cancer Res., July 1, 2007; 5(7): 713 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Rellos, F. J. Ivins, J. E. Baxter, A. Pike, T. J. Nott, D.-M. Parkinson, S. Das, S. Howell, O. Fedorov, Q. Y. Shen, et al.
Structure and Regulation of the Human Nek2 Centrosomal Kinase
J. Biol. Chem., March 2, 2007; 282(9): 6833 - 6842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Buscemi, L. Carlessi, L. Zannini, S. Lisanti, E. Fontanella, S. Canevari, and D. Delia
DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues
Mol. Cell. Biol., November 1, 2006; 26(21): 7832 - 7845.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Takemura, V. A. Rao, O. Sordet, T. Furuta, Z.-H. Miao, L. Meng, H. Zhang, and Y. Pommier
Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks
J. Biol. Chem., October 13, 2006; 281(41): 30814 - 30823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yang, J.-H. Jeong, A. L. Brown, C.-H. Lee, P. P. Pandolfi, J. H. Chung, and M. K. Kim
Promyelocytic Leukemia Activates Chk2 by Mediating Chk2 Autophosphorylation
J. Biol. Chem., September 8, 2006; 281(36): 26645 - 26654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Yoda, X. Z. Xu, N. Onishi, K. Toyoshima, H. Fujimoto, N. Kato, I. Oishi, T. Kondo, and Y. Minami
Intrinsic Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by Wip1
J. Biol. Chem., August 25, 2006; 281(34): 24847 - 24862.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
O Kilpivaara, P Alhopuro, P Vahteristo, L A Aaltonen, and H Nevanlinna
CHEK2 I157T associates with familial and sporadic colorectal cancer.
J. Med. Genet., July 1, 2006; 43(7): e34 - e34.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Ma, S.-J. Lee, J. K. Duong, and D. F. Stern
Activation of the Checkpoint Kinase Rad53 by the Phosphatidyl Inositol Kinase-like Kinase Mec1
J. Biol. Chem., February 17, 2006; 281(7): 3954 - 3963.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Gibson, R. S. Bindra, and P. M. Glazer
Hypoxia-Induced Phosphorylation of Chk2 in an Ataxia Telangiectasia Mutated-Dependent Manner
Cancer Res., December 1, 2005; 65(23): 10734 - 10741.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C.-M. Aliouat-Denis, N. Dendouga, I. Van den Wyngaert, H. Goehlmann, U. Steller, I. van de Weyer, N. Van Slycken, L. Andries, S. Kass, W. Luyten, et al.
p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by Chk2
Mol. Cancer Res., November 1, 2005; 3(11): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-R. Chen, W. Wang, H. A. Rogoff, X. Li, W. Mang, and C. J. Li
Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation as a Strategy against Cancer
Cancer Res., July 15, 2005; 65(14): 6017 - 6021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Wei, Y.-F. Chou, Y.-H. Ou, Y.-H. Yeh, S.-W. Tyan, T.-P. Sun, C.-Y. Shen, and S.-Y. Shieh
TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68
J. Biol. Chem., March 4, 2005; 280(9): 7748 - 7757.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. D. McSherry and P. R. Mueller
Xenopus Cds1 Is Regulated by DNA-Dependent Protein Kinase and ATR during the Cell Cycle Checkpoint Response to Double-Stranded DNA Ends
Mol. Cell. Biol., November 15, 2004; 24(22): 9968 - 9985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Tosti, L. Waldbaum, G. Warshaw, E. A. Gross, and R. Ruggieri
The Stress Kinase MRK Contributes to Regulation of DNA Damage Checkpoints through a p38{gamma}-independent Pathway
J. Biol. Chem., November 12, 2004; 279(46): 47652 - 47660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Jack, R. A. Woo, N. Motoyama, H. Takai, and P. W. K. Lee
DNA-dependent Protein Kinase and Checkpoint Kinase 2 Synergistically Activate a Latent Population of p53 upon DNA Damage
J. Biol. Chem., April 9, 2004; 279(15): 15269 - 15273.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. A. Rogoff, M. T. Pickering, F. M. Frame, M. E. Debatis, Y. Sanchez, S. Jones, and T. F. Kowalik
Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2
Mol. Cell. Biol., April 1, 2004; 24(7): 2968 - 2977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-P. Ng, H. C. Lee, C. W. Ho, T. Arooz, W. Y. Siu, A. Lau, and R. Y. C. Poon
Differential Mode of Regulation of the Checkpoint Kinases CHK1 and CHK2 by Their Regulatory Domains
J. Biol. Chem., March 5, 2004; 279(10): 8808 - 8819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.